FOCAL CAP FIRST-LINE OBJECTIVE CLINICAL ASSESSMENT OF FOCAL TREATMENT IN LOW-RISK LOCALIZED CANCER OF THE PROSTATE

Pharmaceuticals and 3 others

Owner

STEBA FRANCE

Mar 17, 2009